Genesis Therapeutics appoints Aleksandra Faust as Chief Artificial Intelligence Officer

Read More →

Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration

Incyte and Genesis will leverage Genesis’ GEMS artificial intelligence (AI) platform to unlock the discovery of breakthrough small molecule therapeutics...

Read More →

Genesis Therapeutics Expands Leadership Team with Appointments of Chief Scientific Officer, SVP of Engineering, and Board Chairman

Read More →

Genesis Therapeutics Announces New Equity Investment and Collaboration with NVIDIA to Optimize Key Computational Methods for AI-powered Drug Discovery

Read More →

Gilead partners with AI startup Genesis Therapeutics to make small molecule drugs

Read More →

Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies

Gilead and Genesis will leverage the GEMS AI platform to generate and jointly optimize molecules against selected targets. Genesis will...

Read More →